ROYCE & ASSOCIATES LP

Position in RGEN — Repligen Corp

CIK 906304 New York, NY

Position in RGEN

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$13,659,108

-$10,423,887 QoQ

Shares Held

115,932

-21.1% QoQ

Ownership

0.206%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ROYCE & ASSOCIATES LP holds $114,889,031 across 12 Medical Instruments & Supplies names. RGEN ranks #3 (11.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NVST	Envista Holdings Corp	978,447	$24,823,200
2	ANGO	Angiodynamics Inc	1,528,951	$17,384,172
3	RGEN	Repligen Corp This page	115,932	$13,659,108
4	STVN	Stevanato Group S.p.A.	841,326	$11,568,232
5	AVTR	Avantor, Inc.	1,463,622	$11,474,796
6	BLFS	Biolife Solutions Inc	584,011	$11,142,929
7	AZTA	Azenta, Inc.	523,308	$11,057,498
8	TFX	Teleflex Inc	55,530	$6,641,943

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$13,659,108	115,932	-21.1%	Shares	Sole	2026-05-12
2025-12-31	$24,082,995	146,973	-1.1%	Shares	Sole	2026-02-09
2025-09-30	$19,871,114	148,658	+66.1%	Shares	Sole	2025-11-12
2025-06-30	$11,134,746	89,522	+733.6%	Shares	Sole	2025-08-11
2023-03-31	$1,808,018	10,739	-88.4%	Shares	Sole	2023-05-23
2022-12-31	$15,650,847	92,439	-7.6%	Shares	Sole	2023-05-23
2022-09-30	$18,728,588	100,094	-21.3%	Shares	Sole	2022-11-03
2022-06-30	$20,660,365	127,219	+41.0%	Shares	Sole	2022-08-04
2022-03-31	$16,965,718	90,200	—	Shares	Sole	2022-05-05
No filing history on record for this holder in this stock.